Add like
Add dislike
Add to saved papers

Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors.

Radiology 2012 June
PURPOSE: To prospectively evaluate the intravoxel incoherent motion (IVIM) parameters (microvascular volume fraction, f; pure diffusion coefficient, D; and perfusion-related incoherent microcirculation, D*) for differentiating between benign and malignant salivary gland tumors.

MATERIALS AND METHODS: All participants in this prospective institutional review board-approved study provided written informed consent. The perfusion and diffusion of 20 (65%) benign (12 pleomorphic adenomas and eight Warthin tumors) and 11 (35%) malignant salivary gland tumors were assessed on the basis of the IVIM theory. Diffusion-weighted magnetic resonance imaging was performed by using 11 b values (0-800 sec/mm(2)). The IVIM parameters of the salivary gland tumors were determined by a radiologist, and significant differences between the tumor types were assessed by using the Steel-Dwass test.

RESULTS: The f values of Warthin tumors (0.156 ± 0.039 [standard deviation]) were significantly larger than those of pleomorphic adenomas (0.066 ± 0.031) (P = .003). The D values of malignant tumors (0.96 × 10(-3) mm(2)/sec ± 0.22) were significantly different from those of benign tumors (pleomorphic adenomas, 1.38 × 10(-3) mm(2)/sec ± 0.30 [P = .002]; Warthin tumors, 0.61 × 10(-3) mm(2)/sec ± 0.11 [P = .005]). The D* values of malignant tumors (21.99 × 10(-3) mm(2)/sec ± 19.01) were significantly smaller than those of Warthin tumors (42.64 × 10(-3) mm(2)/sec ± 20.17) (P = .022). The combination of D and D* criteria provided the best diagnostic accuracy (100%) for differentiation among the three tumor types.

CONCLUSION: IVIM imaging may be helpful for differentiation between benign and malignant salivary gland tumors.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app